- Product Details
- Description
- Additional information
- More Offers
Description
Background Information:
ABT-263 (Navitoclax) is a potent, selective and orally bioavailable inhibitor of B-cell lymphoma-2 (BCL-2) family proteins, binding potently to both BCL-2 and BCL-XL with Ki values of <1 nM.
Reference:
1. Tse C et al., ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor. Cancer Res. 2008 May 1;68(9):3421-8.
APIM050005: ABT-263 (NOVITOCLAX)
CAS No.: 923564-51-6
Molecular Formula: C47H55ClF3N5O6S3
Molecular Weight: 974.6
Purity: >99% by HPLC, 100% optical purity (Chiral HPLC)
QC: HPLC-MS, 1HNMR, Chiral HPLC, and Quantitative Elemental Analysis
Solubility: DMSO.
Storage: Store at 0°C (short term), -20°C (long term), desiccated.
Additional information
| Ship from Country | USA |
|---|---|
| Size | 10 mg, 100 mg, 200 mg, 50 mg |
No more offers for this product!
